Japanese Pharmacology & Therapeutics(JPT)
Vol. 29 No. 1 2001
Recent Development of Clinical Trials for Hyperlipidemia and Arteriosclerosis
T.Teramoto
Jpn Pharmacol Ther 2001 29(1) 9-15
Experimental Analysis of Theophylline-induced Emetic Response in Pigeons
S.Tanihata, et al.
Jpn Pharmacol Ther 2001 29(1) 19-24
Comparative Analysis of Nontoxigenic and Neurotoxigenic Clostridium butyricum by Molecular Typing Methods
H. Akamatsu, et al.
Jpn Pharmacol Ther 2001 29(1) 25-8
K. Tashima, et al.
Jpn Pharmacol Ther 2001 29(1) 29-35
Study of Interactions Among Colestimide and Drugs(2nd Report)
-Comparison with Cholestyramine-
K. Suzuki, et al.
Jpn Pharmacol Ther 2001 29(1) 37-44
S. Matsumoto, et al.
Jpn Pharmacol Ther 2001 29(1) 45-50
Effect of NK-104, an HMG-CoA Reductase Inhibitor on Lipid Metabolism in HepG2 Cells
S. NAkagawa, et al.
Jpn Pharmacol Ther 2001 29(1) 51-7
General Pharmacological Study of an Anti-hyperlipidemic Agent, NK-104
Y. Yoshinaka, et al.
Jpn Pharmacol Ther 2001 29(1) 59-72
T. Nakane, et al.
Jpn Pharmacol Ther 2001 29(1) 73-87